These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12692352)

  • 1. The expression of matrix metalloproteinase-1 mRNA induced by ultraviolet A1 (340-400 nm) is phototherapy relevant to the glutathione (GSH) content in skin fibroblasts of systemic sclerosis.
    Yin L; Yamauchi R; Tsuji T; Krutmann J; Morita A
    J Dermatol; 2003 Mar; 30(3):173-80. PubMed ID: 12692352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tempol, one of nitroxides, is a novel ultraviolet-A1 radiation protector for human dermal fibroblasts.
    Yan SX; Hong XY; Hu Y; Liao KH
    J Dermatol Sci; 2005 Mar; 37(3):137-43. PubMed ID: 15734282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological effects of a new ultraviolet A
    Arndt S; Lissner C; Unger P; Bäumler W; Berneburg M; Karrer S
    Exp Dermatol; 2020 Dec; 29(12):1199-1208. PubMed ID: 32592187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis.
    Morita A; Kobayashi K; Isomura I; Tsuji T; Krutmann J
    J Am Acad Dermatol; 2000 Oct; 43(4):670-4. PubMed ID: 11004624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sunscreens with an absorption maximum of > or =360 nm provide optimal protection against UVA1-induced expression of matrix metalloproteinase-1, interleukin-1, and interleukin-6 in human dermal fibroblasts.
    Vielhaber G; Grether-Beck S; Koch O; Johncock W; Krutmann J
    Photochem Photobiol Sci; 2006 Mar; 5(3):275-82. PubMed ID: 16520862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered decorin expression of systemic sclerosis by UVA1 (340-400 nm) phototherapy: immunohistochemical analysis of 3 cases.
    Sawada H; Isogai Z; Morita A
    BMC Dermatol; 2003 Mar; 3():2. PubMed ID: 12689342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic exposure of interleukin-13 suppress the induction of matrix metalloproteinase-1 by tumour necrosis factor α in normal and scleroderma dermal fibroblasts through protein kinase B/Akt.
    Brown Lobbins ML; Shivakumar BR; Postlethwaite AE; Hasty KA
    Clin Exp Immunol; 2018 Jan; 191(1):84-95. PubMed ID: 28884475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of extracellular matrix induced by tobacco smoke extract.
    Yin L; Morita A; Tsuji T
    Arch Dermatol Res; 2000 Apr; 292(4):188-94. PubMed ID: 10836612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of phospholipid-hydroperoxide glutathione peroxidase in human dermal fibroblasts abrogates UVA irradiation-induced expression of interstitial collagenase/matrix metalloproteinase-1 by suppression of phosphatidylcholine hydroperoxide-mediated NFkappaB activation and interleukin-6 release.
    Wenk J; Schüller J; Hinrichs C; Syrovets T; Azoitei N; Podda M; Wlaschek M; Brenneisen P; Schneider LA; Sabiwalsky A; Peters T; Sulyok S; Dissemond J; Schauen M; Krieg T; Wirth T; Simmet T; Scharffetter-Kochanek K
    J Biol Chem; 2004 Oct; 279(44):45634-42. PubMed ID: 15308634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose UVA1 phototherapy in systemic sclerosis: effects on acrosclerosis.
    Kreuter A; Breuckmann F; Uhle A; Brockmeyer N; Von Kobyletzki G; Freitag M; Stuecker M; Hoffmann K; Gambichler T; Altmeyer P
    J Am Acad Dermatol; 2004 May; 50(5):740-7. PubMed ID: 15097958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of UVA1 on hypertrophic scarring in the rabbit ear model.
    Zhang T; Shen Z; Zheng J; Jiang R
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts.
    Fineschi S; Cozzi F; Burger D; Dayer JM; Meroni PL; Chizzolini C
    Rheumatology (Oxford); 2007 Dec; 46(12):1779-85. PubMed ID: 17982166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the immunosuppressant rapamycin on the expression of human α2(I) collagen and matrix metalloproteinase 1 genes in scleroderma dermal fibroblasts.
    Tamaki Z; Asano Y; Kubo M; Ihn H; Tada Y; Sugaya M; Kadono T; Sato S
    J Dermatol Sci; 2014 Jun; 74(3):251-9. PubMed ID: 24630239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of (-)-epigallocatechin-3-gallate on expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in fibroblasts irradiated with ultraviolet A.
    Song XZ; Xia JP; Bi ZG
    Chin Med J (Engl); 2004 Dec; 117(12):1838-41. PubMed ID: 15603715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma.
    Kreuter A; Hyun J; Skrygan M; Sommer A; Bastian A; Altmeyer P; Gambichler T
    Br J Dermatol; 2006 Sep; 155(3):600-7. PubMed ID: 16911288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of granulocyte macrophage-colony stimulating factor on extracellular matrix deposition by dermal fibroblasts from patients with scleroderma.
    Postiglione L; Ladogana P; Montagnani S; di Spigna G; Castaldo C; Turano M; Bruno EM; Di Meglio F; Riccio A; Rossi G
    J Rheumatol; 2005 Apr; 32(4):656-64. PubMed ID: 15801021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis.
    Kawaguchi Y; Harigai M; Hara M; Fukasawa C; Takagi K; Tanaka M; Tanaka E; Nishimagi E; Kamatani N
    J Rheumatol; 2002 Sep; 29(9):1877-83. PubMed ID: 12233882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome blockade exerts an antifibrotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and up-regulating metalloproteinase-1 production in human dermal fibroblasts.
    Fineschi S; Reith W; Guerne PA; Dayer JM; Chizzolini C
    FASEB J; 2006 Mar; 20(3):562-4. PubMed ID: 16410344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.